IXENSOR CO., LTD.
Update：2026/08/06
Industries
Main Industry
Health Care
Main Product/Service
1. PixoTest® POCT COVID-19 Antigen Test
2. PixoTest® Blood Glucose Monitoring System
3. PixoTest® POCT System for HbA1c, Lipid Panel
4. Eveline® Smart Fertility System
5. Eveline‧Care Telehealth Platform
6. PixoTech® Platform
2. PixoTest® Blood Glucose Monitoring System
3. PixoTest® POCT System for HbA1c, Lipid Panel
4. Eveline® Smart Fertility System
5. Eveline‧Care Telehealth Platform
6. PixoTech® Platform
Founded Year
2012
Unified Business No.
53927676
Status
Active
Number of Employees
35
Total Paid-in
Capital
406,231,640 (NT$)
Location of Company
Taiwan
, Taipei City
Exit Status
Emerging Stock Exchange(2025)
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
iXensor is the global pioneer of mobile health.
We turn ordinary smartphones into versatile lab-grade medical diagnostic devices for point-of-care testing and at-home self-testing solutions. PixoTest®, our first product, is also the world's first FDA approved smartphone camera-based blood test dated back in 2017.
Founded at StanfordUniversity, Palo Alto, and incorporated in Taipei, Taiwan, in 2012, our international team combines expertise in medical engineering, biochemistry, and information technology to develop innovative health-tech products and digital health solutions that empower the connected healthcare of tomorrow.
Our product lines cover Women’s Health, Chronic, and Infectious Diseases are all powered by our core technology - PixoTech® platform. It serves as our engine for the next phase of growth.
We have received many international awards for our innovation, and our business has also been accelerated by Merck Accelerator, Plug & Play’s Creasphere, and Johnson & Johnson Innovation’s JLABs.
We turn ordinary smartphones into versatile lab-grade medical diagnostic devices for point-of-care testing and at-home self-testing solutions. PixoTest®, our first product, is also the world's first FDA approved smartphone camera-based blood test dated back in 2017.
Founded at StanfordUniversity, Palo Alto, and incorporated in Taipei, Taiwan, in 2012, our international team combines expertise in medical engineering, biochemistry, and information technology to develop innovative health-tech products and digital health solutions that empower the connected healthcare of tomorrow.
Our product lines cover Women’s Health, Chronic, and Infectious Diseases are all powered by our core technology - PixoTech® platform. It serves as our engine for the next phase of growth.
We have received many international awards for our innovation, and our business has also been accelerated by Merck Accelerator, Plug & Play’s Creasphere, and Johnson & Johnson Innovation’s JLABs.
